edoc

Items where contributor is "Ladanie, Aviv"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2018

2018

Ladanie, Aviv and Ioannidis, John P. A. and Stafford, Randall S. and Ewald, Hannah and Bucher, Heiner C. and Hemkens, Lars G.. (2018) Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials. Journal of clinical epidemiology, 94. pp. 35-45.

Ladanie, Aviv and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2018) The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials, 19 (1). p. 505.

Ladanie, Aviv. Epidemiology and characteristics of clinical trials supporting US FDA approval of novel cancer drugs. 2018, Doctoral Thesis, University of Basel, Faculty of Science.